Title : Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells.

Pub. Date : 2020 Jan 20

PMID : 31968611






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We tested the synergistic effect of ticagrelor, a P2Y12 inhibitor, in combination with chemotherapeutic drugs (gemcitabine, paclitaxel and cisplatin), in vitro and in vivo. ticagrelor purinergic receptor P2Y12 Homo sapiens